Cramer sees Abbott becoming a buying opportunity — but timing is key

Cramer sees Abbott becoming a buying opportunity — but timing is key

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. Wall Street started the week off slightly lower on the last day of September — historically the worst month of the year, but not this year. During Monday’s Morning … Read more

None of our top 5 stocks in the third quarter are in tech

None of our top 5 stocks in the third quarter are in tech

Less than two months ago, Wall Street was in the thick of a global market sell-off, with fears of a U.S. recession intensifying. Now the S & P 500 is on the doorstep of its fourth positive quarter in a row, the longest such streak since 2021. What a difference a little time makes. The … Read more

We ranked Q2 earnings from 30 portfolio stocks from great to ugly

We ranked Q2 earnings from 30 portfolio stocks from great to ugly

It was a solid quarter for the companies in our stock portfolio, with the bulk of our names reporting what we felt were good-to-great earnings reports. Continued economic growth on the back of a resilient consumer and increasing business confidence ahead of what most expect to be a lower interest rate environment helped drive the … Read more

Eli Lilly could become the first $1 trillion healthcare stock

Eli Lilly could become the first  trillion healthcare stock

A sign with the company logo outside the headquarters of Eli Lilly and Company in Indianapolis, Indiana, March 17, 2024. Scott Olson | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Earlier this … Read more

Abbott launches its first over-the-counter continuous glucose monitor in the U.S.

Abbott launches its first over-the-counter continuous glucose monitor in the U.S.

A man wearing Abbott’s Lingo biosensor. Courtesy of Abbott Abbott Laboratories announced Thursday its over-the-counter continuous glucose monitor Lingo is available in the U.S. starting at $49.  Lingo is part of an emerging class of consumer-friendly biosensors that people can use to learn how their bodies respond to food, exercise, sleep and stress. These devices, … Read more

Dexcom launches Stelo, its first over-the-counter continuous glucose monitor

Dexcom launches Stelo, its first over-the-counter continuous glucose monitor

Zoom In IconArrows pointing outwards User wearing Stelo CGM from Dexcom. Courtesy of Dexcom Dexcom on Monday announced its new over-the-counter continuous glucose monitor Stelo is officially available for purchase in the U.S. Glucose is a type of sugar people receive from food, and it’s the body’s main source of energy. Continuous glucose monitors, or … Read more

2 big tests ahead will determine if last week’s stock market excitement was warranted

2 big tests ahead will determine if last week’s stock market excitement was warranted

Wall Street takes back-to-back weekly gains and an overbought market into an important week featuring Nvidia earnings and the latest reading on the Federal Reserve’s favorite inflation gauge. Fed Chairman Jerome Powell on Friday gave the speech from Jackson Hole that investors wanted to hear. The S & P 500 and Nasdaq bounced back from … Read more

Jim Cramer looks at reasons for the market decline and 3 stocks movers

Jim Cramer looks at reasons for the market decline and 3 stocks movers

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets drop: Wall Street struggled to hold onto its early gains and moved lower. We’re not surprised to see the market take a breather after its … Read more

After a busy week of trades, we’re looking to some key inflation data

After a busy week of trades, we’re looking to some key inflation data

It was another volatile week for stocks, but Wall Street ultimately finished lower again. The market experienced a sharp sell-off Monday on recession concerns, which led the S & P 500 and Dow Jones Industrial Average to its worst single-day performances since 2022. The VIX index — Wall Street’s fear gauge and a measure of … Read more

We’re encouraged by Abbott stock trading but discouraged by moves in Honeywell

We’re encouraged by Abbott stock trading but discouraged by moves in Honeywell

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market moves: The S & P 500 was on track for small gains following a solid rally last Friday. There’s still some market rotation happening, but … Read more